 the rate of AAA expansion in mice, but clinical
investigations have reported conï¬‚icting results.291,292
Clinical trials of b-adrenergic receptor blockade demonstrate no effect on the rate of aneurysm progression.285,286 Likewise, beta blockade, lipid-lowering
agents, and angiotensin receptor blockade do not
appear to alter rupture risk, but an increased risk of
rupture has been reported for patients